Barriers and facilitators to the uptake of new medicines into clinical practice: a systematic review
Background Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (s...
Uložené v:
| Vydané v: | BMC health services research Ročník 21; číslo 1; s. 1198 - 28 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
BioMed Central
05.11.2021
BioMed Central Ltd Springer Nature B.V BMC |
| Predmet: | |
| ISSN: | 1472-6963, 1472-6963 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background
Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research.
Method
A systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them.
Results
A total of 66 studies were included. Most studies (
n
= 62) were quantitative and used secondary data (
n
= 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored.
Conclusion
This systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines.
Registration
PROSPERO database (CRD42018108536). |
|---|---|
| AbstractList | Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research. A systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them. A total of 66 studies were included. Most studies (n = 62) were quantitative and used secondary data (n = 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored. This systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines. Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research.BACKGROUNDImplementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research.A systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them.METHODA systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them.A total of 66 studies were included. Most studies (n = 62) were quantitative and used secondary data (n = 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored.RESULTSA total of 66 studies were included. Most studies (n = 62) were quantitative and used secondary data (n = 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored.This systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines.CONCLUSIONThis systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines.PROSPERO database (CRD42018108536).REGISTRATIONPROSPERO database (CRD42018108536). Background Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research. Method A systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them. Results A total of 66 studies were included. Most studies ( n = 62) were quantitative and used secondary data ( n = 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored. Conclusion This systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines. Registration PROSPERO database (CRD42018108536). Abstract Background Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research. Method A systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them. Results A total of 66 studies were included. Most studies (n = 62) were quantitative and used secondary data (n = 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored. Conclusion This systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines. Registration PROSPERO database (CRD42018108536). Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research. A systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them. A total of 66 studies were included. Most studies (n = 62) were quantitative and used secondary data (n = 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored. This systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines. PROSPERO database (CRD42018108536). Background Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research. Method A systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them. Results A total of 66 studies were included. Most studies (n = 62) were quantitative and used secondary data (n = 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored. Conclusion This systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines. Registration PROSPERO database (CRD42018108536). Keywords: New medicines, Uptake, Implementation, Systematic review, Innovation implementation, Healthcare organizations Background Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new medicines into practice faces a wide range of obstacles. Earlier reviews provided insights into determinants for new medicine uptake (such as medicine, prescriber, patient, organization, and external environment factors). However, the methodological approaches used had limitations (e.g., single author, narrative review, narrow search, no quality assessment of reviewed evidence). This systematic review aims to identify barriers and facilitators affecting the uptake of new medicines into clinical practice and identify areas for future research. Method A systematic search of literature was undertaken within seven databases: Medline, EMBASE, Web of Science, CINAHL, Cochrane Library, SCOPUS, and PsychINFO. Included in the review were qualitative, quantitative, and mixed-methods studies focused on adult participants (18 years and older) requiring or taking new medicine(s) for any condition, in the context of healthcare organizations and which identified factors affecting the uptake of new medicines. The methodological quality was assessed using QATSDD tool. A narrative synthesis of reported factors was conducted using framework analysis and a conceptual framework was utilised to group them. Results A total of 66 studies were included. Most studies (n = 62) were quantitative and used secondary data (n = 46) from various databases, e.g., insurance databases. The identified factors had a varied impact on the uptake of the different studied new medicines. Differently from earlier reviews, patient factors (patient education, engagement with treatment, therapy preferences), cost of new medicine, reimbursement and formulary conditions, and guidelines were suggested to influence the uptake. Also, the review highlighted that health economics, wider organizational factors, and underlying behaviours of adopters were not or under explored. Conclusion This systematic review has identified a broad range of factors affecting the uptake of new medicines within healthcare organizations, which were grouped into patient, prescriber, medicine, organizational, and external environment factors. This systematic review also identifies additional factors affecting new medicine use not reported in earlier reviews, which included patient influence and education level, cost of new medicines, formulary and reimbursement restrictions, and guidelines. Registration PROSPERO database (CRD42018108536). |
| ArticleNumber | 1198 |
| Audience | Academic |
| Author | Petty, Duncan Medlinskiene, Kristina Richardson, Sue Tomlinson, Justine Marques, Iuri Stirling, Katherine |
| Author_xml | – sequence: 1 givenname: Kristina orcidid: 0000-0002-6721-3399 surname: Medlinskiene fullname: Medlinskiene, Kristina email: k.medlinskiene1@bradford.ac.uk, kristina.medlinskiene@nhs.net organization: Medicine Optimisation Research Group, School of Pharmacy and Medical Sciences, University of Bradford, Medicine Management and Pharmacy Services, Leeds Teaching Hospitals NHS Trust – sequence: 2 givenname: Justine surname: Tomlinson fullname: Tomlinson, Justine organization: Medicine Optimisation Research Group, School of Pharmacy and Medical Sciences, University of Bradford, Medicine Management and Pharmacy Services, Leeds Teaching Hospitals NHS Trust – sequence: 3 givenname: Iuri surname: Marques fullname: Marques, Iuri organization: Medicine Optimisation Research Group, School of Pharmacy and Medical Sciences, University of Bradford – sequence: 4 givenname: Sue surname: Richardson fullname: Richardson, Sue organization: Department of Management, Huddersfield Business School, University of Huddersfield – sequence: 5 givenname: Katherine surname: Stirling fullname: Stirling, Katherine organization: Medicine Management and Pharmacy Services, Leeds Teaching Hospitals NHS Trust – sequence: 6 givenname: Duncan surname: Petty fullname: Petty, Duncan organization: Medicine Optimisation Research Group, School of Pharmacy and Medical Sciences, University of Bradford |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34740338$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UsluFDEUbKEgssAPcECWuHDp4KXbCwekJGKJFIkLnK3XXiYeeuzB7kmUv8edCUkmQpEPtp-r6rme6rDZiym6pnlL8DEhkn8shCrCWkxJiwVRvO1eNAekE7TlirO9R-f95rCUJcZESCpeNfusEx1mTB409hRyDi4XBNEiDyaMYYIp1cKU0HTp0GY9wW-HkkfRXaOVs8GE6AoKsQLMGGIwMKJ1BjMF4z4hQOWmTG4F9Yqyuwru-nXz0sNY3Ju7_aj59fXLz7Pv7cWPb-dnJxet4VhMret7OyjLMPQAfABuB0_rrnhPJYZOWas8x33HCBaSARBCPIC3wAXFsmNHzflW1yZY6nUOK8g3OkHQt4WUFxpy_dbotByYlxS8J8p0BjOglnHCmePGmoGzqvV5q7XeDNW0cXHKMO6I7r7EcKkX6UrLXmCMRRX4cCeQ05-NK5NehWLcOEJ0aVM07VVHFSMdqdD3T6DLtMmxjmpGqWpNMPmAWkA1EKJPta-ZRfUJl4T3ivF5Bsf_QdVl3SqYGiAfan2H8O6x0XuH_zJSAXQLMDmVkp2_hxCs5yDqbRB1DaK-DaKeVeUTkplzFdI8rDA-T2Vbaql94sLlh2k8w_oLQTvxjQ |
| CitedBy_id | crossref_primary_10_1007_s40801_025_00494_x crossref_primary_10_1007_s40290_025_00581_y crossref_primary_10_1007_s40290_025_00566_x crossref_primary_10_1080_13696998_2025_2520182 crossref_primary_10_1038_s41598_023_44165_9 crossref_primary_10_1136_bmjopen_2022_069575 crossref_primary_10_1186_s12890_022_02196_4 crossref_primary_10_1245_s10434_025_17979_2 crossref_primary_10_1186_s12913_025_12601_3 crossref_primary_10_1016_j_sapharm_2022_07_003 crossref_primary_10_1161_CIRCULATIONAHA_122_059032 crossref_primary_10_3389_fspor_2022_981656 crossref_primary_10_1371_journal_pone_0307086 crossref_primary_10_1007_s12325_025_03241_4 crossref_primary_10_1097_XEB_0000000000000398 crossref_primary_10_1186_s40545_023_00529_0 crossref_primary_10_3390_jpm14101032 crossref_primary_10_1038_s41571_022_00700_7 crossref_primary_10_1111_hex_70366 crossref_primary_10_1007_s12325_023_02611_0 crossref_primary_10_1016_j_urolonc_2024_07_014 crossref_primary_10_1111_dom_15682 crossref_primary_10_1108_JHOM_06_2023_0203 crossref_primary_10_1007_s40259_025_00732_2 crossref_primary_10_1080_14737175_2023_2174430 crossref_primary_10_1101_gad_352629_125 crossref_primary_10_21802_artm_2024_1_29_212 crossref_primary_10_1186_s13690_024_01261_0 crossref_primary_10_1159_000539524 crossref_primary_10_1177_21501319221147254 crossref_primary_10_3390_cancers16183187 crossref_primary_10_1186_s40246_023_00509_0 crossref_primary_10_1016_j_pcd_2024_12_011 crossref_primary_10_1186_s12916_024_03775_4 crossref_primary_10_2196_50419 crossref_primary_10_1016_j_jcjd_2024_10_011 crossref_primary_10_1001_jamanetworkopen_2025_8296 crossref_primary_10_1186_s12913_024_11305_4 crossref_primary_10_1016_j_xjtc_2025_05_005 crossref_primary_10_1111_bju_16570 crossref_primary_10_1016_j_jcf_2023_11_012 crossref_primary_10_1001_jamacardio_2024_3815 crossref_primary_10_1111_cas_15322 crossref_primary_10_1111_ijd_17236 crossref_primary_10_1177_20552076231180970 crossref_primary_10_1016_j_jcpo_2022_100362 crossref_primary_10_1212_CPJ_0000000000200392 |
| Cites_doi | 10.1111/j.1365-2710.2008.00875.x 10.1097/MLR.0000000000000329 10.1111/jep.13297 10.1186/1748-5908-4-50 10.1186/s12913-019-3889-4 10.1016/j.jsat.2008.12.004 10.1111/ecc.12624 10.1186/s13104-018-3597-x 10.1016/j.jsat.2008.06.006 10.1001/jamanetworkopen.2019.18586 10.1161/CIRCOUTCOMES.114.000907 10.3389/fpubh.2018.00328 10.1108/S0731-2199(2012)0000023008 10.1016/j.jchf.2016.12.018 10.1186/1472-6963-11-21 10.1186/s13012-015-0242-0 10.1007/s10461-011-0107-8 10.1161/CIRCHEARTFAILURE.118.005400 10.3109/02813432.2011.570024 10.1016/j.ahj.2018.01.009 10.1111/j.1365-2753.2012.01886.x 10.1186/1471-2288-13-37 10.4324/9780203413081_chapter_9 10.1136/bmj.f264 10.1007/s11096-012-9694-3 10.1186/1472-6963-12-56 10.1161/JAHA.113.000535 10.1186/s12885-020-6583-3 10.1016/j.healthpol.2015.02.016 10.1097/MLR.0000000000000549 10.1007/s10198-011-0311-5 10.1007/s00038-010-0132-9 10.1371/journal.pmed.1000097 10.1186/1748-5908-8-22 10.1111/j.1365-2710.2008.00925.x 10.18553/jmcp.2019.25.1.072 10.1016/j.ijcard.2020.01.029 10.1016/j.sapharm.2009.09.003 10.1007/s10198-009-0174-1 10.1016/j.hjdsi.2017.09.004 10.1287/mksc.1100.0566 10.1186/1747-597X-3-17 10.1007/s00228-008-0549-8 10.1038/bjc.2014.86 10.1007/s12325-017-0589-5 10.1200/JOP.2011.000287 10.1362/026725707X196404 10.1016/j.socscimed.2010.12.027 10.1177/1747493017733928 10.1287/mksc.1070.0354 10.1111/j.1751-7176.2012.00651.x 10.1111/j.1365-2753.2011.01662.x 10.1016/j.socscimed.2016.11.010 10.1176/appi.ps.201200186 10.1186/1472-6963-14-310 10.1177/0020731415585986 10.1111/jcpt.12490 10.1016/j.seizure.2007.11.005 10.1111/bcp.14171 10.1016/j.jval.2011.11.025 10.2190/PM.42.4.b 10.1186/1472-6963-14-469 10.18433/J30W4F 10.1186/s13012-014-0196-7 10.1007/s10754-009-9062-6 10.1371/journal.pmed.1000100 10.1016/j.socscimed.2011.06.065 10.1097/MLR.0000000000000840 10.1007/s11414-009-9169-z 10.1111/j.1540-5885.2012.00912.x 10.1007/s00228-008-0569-4 10.1258/jrsm.2011.110180 10.1007/s00198-014-3023-8 10.1007/s11129-009-9072-1 10.1371/journal.pone.0204826 10.1161/JAHA.118.010484 10.18553/jmcp.2016.22.3.281 10.1016/j.hlpt.2020.02.007 10.1016/j.jsat.2010.01.003 10.1016/j.jsat.2011.06.009 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 2021. The Author(s). COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. The Author(s). – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7WY 7WZ 7X7 7XB 87Z 88C 88E 8FI 8FJ 8FK 8FL ABUWG AFKRA AZQEC BENPR BEZIV CCPQU DWQXO FRNLG FYUFA F~G GHDGH K60 K6~ K9. KB0 L.- M0C M0S M0T M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQBIZ PQBZA PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA |
| DOI | 10.1186/s12913-021-07196-4 |
| DatabaseName | Springer Nature OA Free Journals (WRLC) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database ABI/INFORM Collection ABI/INFORM Global (PDF only) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ABI/INFORM Global (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ABI/INFORM Collection (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Business Premium Collection ProQuest One Community College ProQuest Central Korea Business Premium Collection (Alumni) Proquest Health Research Premium Collection ABI/INFORM Global (Corporate) Health Research Premium Collection (Alumni) ProQuest Business Collection (Alumni Edition) ProQuest Business Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ABI/INFORM Professional Advanced ABI/INFORM Global Health & Medical Collection (Alumni Edition) Healthcare Administration Database Medical Database Nursing & Allied Health Premium ProQuest One Academic ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Business ProQuest One Business (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ABI/INFORM Global (Corporate) ProQuest Business Collection (Alumni Edition) ProQuest One Business ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ABI/INFORM Complete ProQuest Central ABI/INFORM Professional Advanced ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ABI/INFORM Complete (Alumni Edition) Business Premium Collection ABI/INFORM Global ABI/INFORM Global (Alumni Edition) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Business Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest One Business (Alumni) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Business Premium Collection (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1472-6963 |
| EndPage | 28 |
| ExternalDocumentID | oai_doaj_org_article_8b3f82aff19c4c03a2d36163e6cdcb63 PMC8570007 A681659364 34740338 10_1186_s12913_021_07196_4 |
| Genre | Systematic Review Journal Article |
| GeographicLocations | United Kingdom United Kingdom--UK |
| GeographicLocations_xml | – name: United Kingdom – name: United Kingdom--UK |
| GrantInformation_xml | – fundername: Pharmacy Research UK grantid: PRUK-2018-GA-1-KM – fundername: Leeds Teaching Hospitals NHS Trust – fundername: ; – fundername: ; grantid: PRUK-2018-GA-1-KM |
| GroupedDBID | --- 0R~ 23N 2WC 44B 53G 5VS 6J9 6PF 7RV 7WY 7X7 88E 8FI 8FJ 8FL AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BEZIV BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 DWQXO E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FRNLG FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC K60 K6~ KQ8 M0C M0T M1P M48 M~E NAPCQ O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQBIZ PQBZA PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC K9. L.- PKEHL PQEST PQUKI Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c607t-e55db9d30a5aa6ba6dbf26ba965280a49dd9f6054310783aa111faafda6720843 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 57 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000714917700005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1472-6963 |
| IngestDate | Mon Nov 10 04:35:56 EST 2025 Tue Nov 04 01:37:36 EST 2025 Thu Sep 04 16:45:00 EDT 2025 Tue Oct 07 05:17:24 EDT 2025 Tue Nov 11 10:24:20 EST 2025 Tue Nov 04 18:03:49 EST 2025 Thu Apr 03 07:03:55 EDT 2025 Sat Nov 29 05:23:42 EST 2025 Tue Nov 18 21:18:20 EST 2025 Sat Sep 06 07:30:36 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | New medicines Systematic review Healthcare organizations Uptake Implementation Innovation implementation |
| Language | English |
| License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-e55db9d30a5aa6ba6dbf26ba965280a49dd9f6054310783aa111faafda6720843 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-6721-3399 |
| OpenAccessLink | https://doaj.org/article/8b3f82aff19c4c03a2d36163e6cdcb63 |
| PMID | 34740338 |
| PQID | 2599084738 |
| PQPubID | 44821 |
| PageCount | 28 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8b3f82aff19c4c03a2d36163e6cdcb63 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8570007 proquest_miscellaneous_2594293141 proquest_journals_2599084738 gale_infotracmisc_A681659364 gale_infotracacademiconefile_A681659364 pubmed_primary_34740338 crossref_primary_10_1186_s12913_021_07196_4 crossref_citationtrail_10_1186_s12913_021_07196_4 springer_journals_10_1186_s12913_021_07196_4 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-11-05 |
| PublicationDateYYYYMMDD | 2021-11-05 |
| PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-05 day: 05 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC health services research |
| PublicationTitleAbbrev | BMC Health Serv Res |
| PublicationTitleAlternate | BMC Health Serv Res |
| PublicationYear | 2021 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | L Shamseer (7196_CR17) 2015; 354 C Tanislav (7196_CR79) 2018; 13 SI Haider (7196_CR43) 2008; 64 HK Knudsen (7196_CR57) 2009; 37 7196_CR5 PJ Wang (7196_CR82) 2010; 55 7196_CR4 7196_CR3 7196_CR12 D Moher (7196_CR14) 2009; 6 R Sirriyeh (7196_CR18) 2012; 18 7196_CR13 HA Huskamp (7196_CR48) 2013; 64 NL Keating (7196_CR52) 2020; 3 YW Wen (7196_CR84) 2011; 11 7196_CR16 M King (7196_CR55) 2013; 346 JL Kereszturi (7196_CR54) 2015; 93 B Zhang (7196_CR86) 2020; 20 A Mason (7196_CR8) 2008; 3 D Chauhan (7196_CR9) 2008; 33 P Boon (7196_CR26) 2008; 17 C Chamberlain (7196_CR31) 2014; 111 CR Hsieh (7196_CR46) 2012; 15 D Sato (7196_CR75) 2012; 34 A Murphy (7196_CR68) 2018; 11 A Lubloy (7196_CR10) 2014; 14 FJ Garjon (7196_CR41) 2012; 12 HC Lin (7196_CR58) 2011; 42 J Bourke (7196_CR27) 2012; 3 7196_CR90 L Ewbank (7196_CR2) 2018 BA Rodwin (7196_CR74) 2020; 304 E Jaakkola (7196_CR88) 2007; 23 A Liberati (7196_CR15) 2009; 6 7196_CR20 L Tobin (7196_CR80) 2008; 37 E Karampli (7196_CR50) 2020; 9 E Carracedo-Martinez (7196_CR30) 2017; 42 N Luo (7196_CR63) 2017; 5 NL Keating (7196_CR51) 2018; 56 RM Conti (7196_CR34) 2012; 23 A AbuDagga (7196_CR22) 2014; 14 M Loughlin (7196_CR11) 2019; 25 GA Chressanthis (7196_CR33) 2012; 14 S Hirunrassamee (7196_CR45) 2009; 9 Q Liu (7196_CR61) 2012; 29 LJ Damschroder (7196_CR87) 2009; 4 T Dybdhal (7196_CR38) 2011; 29 JM Donohue (7196_CR36) 2018; 13 PD Friedman (7196_CR39) 2010; 37 P Nilsen (7196_CR91) 2015; 10 AD DeVore (7196_CR35) 2018; 11 WH Lo-Ciganic (7196_CR62) 2016; 54 TS Anderson (7196_CR24) 2018; 6 RP Hickson (7196_CR44) 2019; 25 C Huang (7196_CR47) 2013; 19 KEM Groves (7196_CR42) 2010; 6 J Netherland (7196_CR69) 2009; 36 ZS Morris (7196_CR1) 2011; 104 PA Patel (7196_CR72) 2015; 8 TS Potpara (7196_CR73) 2017; 34 N Scholten (7196_CR77) 2015; 10 YW Tsai (7196_CR81) 2010; 11 MA Weir (7196_CR83) 2012; 8 N Luo (7196_CR65) 2019; 8 TS Anderson (7196_CR23) 2015; 53 M King (7196_CR56) 2017; 172 M Ohl (7196_CR70) 2013; 17 LJ Ducharme (7196_CR37) 2008; 3 7196_CR40 YM Liu (7196_CR60) 2011; 72 P Manchanda (7196_CR66) 2008; 27 P Nilsen (7196_CR6) 2015; 10 C Carroll (7196_CR19) 2013; 13 RA Hahn (7196_CR89) 2015; 45 SH Baik (7196_CR25) 2016; 22 7196_CR49 E Martin (7196_CR67) 2017; 26 AJ Abraham (7196_CR21) 2010; 38 C Kennedy (7196_CR53) 2020; 86 SR Chaudoir (7196_CR7) 2013; 8 PK Chintagunta (7196_CR32) 2009; 7 SJ Lin (7196_CR59) 2011; 73 BA Steinberg (7196_CR78) 2013; 2 AM Burden (7196_CR29) 2015; 26 N Luo (7196_CR64) 2018; 200 SA Savage (7196_CR76) 2012; 42 Y Zhang (7196_CR85) 2019; 19 C Brais (7196_CR28) 2017; 20 H Ohlsson (7196_CR71) 2009; 65 |
| References_xml | – volume: 3 start-page: 1 issue: 1 year: 2008 ident: 7196_CR8 publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2008.00875.x – volume: 53 start-page: 338 issue: 4 year: 2015 ident: 7196_CR23 publication-title: Med Care doi: 10.1097/MLR.0000000000000329 – volume-title: The rising cost of medicines to the NHS: what is the story? The King’s fund year: 2018 ident: 7196_CR2 – volume: 25 start-page: 911 issue: 6 year: 2019 ident: 7196_CR11 publication-title: J Eval Clin Pract doi: 10.1111/jep.13297 – volume: 4 start-page: 50 issue: 1 year: 2009 ident: 7196_CR87 publication-title: Implement Sci doi: 10.1186/1748-5908-4-50 – volume: 19 start-page: 94 issue: 1 year: 2019 ident: 7196_CR85 publication-title: BMC Health Serv Res doi: 10.1186/s12913-019-3889-4 – volume: 37 start-page: 307 issue: 3 year: 2009 ident: 7196_CR57 publication-title: J Subst Abus Treat doi: 10.1016/j.jsat.2008.12.004 – volume: 26 start-page: e12624 issue: 6 year: 2017 ident: 7196_CR67 publication-title: Eur J Cancer Care doi: 10.1111/ecc.12624 – volume: 11 start-page: 478 issue: 1 year: 2018 ident: 7196_CR68 publication-title: BMC Res Notes doi: 10.1186/s13104-018-3597-x – volume: 36 start-page: 244 issue: 3 year: 2009 ident: 7196_CR69 publication-title: J Subst Abus Treat doi: 10.1016/j.jsat.2008.06.006 – volume: 3 issue: 1 year: 2020 ident: 7196_CR52 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2019.18586 – volume: 8 start-page: 383 issue: 4 year: 2015 ident: 7196_CR72 publication-title: Circ-Cardiovas Qual doi: 10.1161/CIRCOUTCOMES.114.000907 – ident: 7196_CR90 doi: 10.3389/fpubh.2018.00328 – volume: 23 start-page: 123 year: 2012 ident: 7196_CR34 publication-title: Adv Health Econ Health Serv Res doi: 10.1108/S0731-2199(2012)0000023008 – volume: 5 start-page: 305 issue: 4 year: 2017 ident: 7196_CR63 publication-title: JACC Heart Fail doi: 10.1016/j.jchf.2016.12.018 – ident: 7196_CR16 – volume: 11 start-page: 21 issue: 1 year: 2011 ident: 7196_CR84 publication-title: BMC Health Serv Res doi: 10.1186/1472-6963-11-21 – volume: 10 start-page: 53 issue: 1 year: 2015 ident: 7196_CR6 publication-title: Implement Sci doi: 10.1186/s13012-015-0242-0 – volume: 17 start-page: 250 issue: 1 year: 2013 ident: 7196_CR70 publication-title: AIDS Behav doi: 10.1007/s10461-011-0107-8 – volume: 11 issue: 9 year: 2018 ident: 7196_CR35 publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.118.005400 – volume: 29 start-page: 117 issue: 2 year: 2011 ident: 7196_CR38 publication-title: Scand J Prim Health Care doi: 10.3109/02813432.2011.570024 – ident: 7196_CR5 – volume: 354 start-page: i4086 year: 2015 ident: 7196_CR17 publication-title: BMJ – volume: 200 start-page: 134 year: 2018 ident: 7196_CR64 publication-title: Am Heart J doi: 10.1016/j.ahj.2018.01.009 – ident: 7196_CR12 – volume: 19 start-page: 938 issue: 5 year: 2013 ident: 7196_CR47 publication-title: J Eval Clin Pract doi: 10.1111/j.1365-2753.2012.01886.x – volume: 13 start-page: 37 issue: 1 year: 2013 ident: 7196_CR19 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-13-37 – ident: 7196_CR20 doi: 10.4324/9780203413081_chapter_9 – volume: 346 start-page: f264 issue: jan30 5 year: 2013 ident: 7196_CR55 publication-title: BMJ doi: 10.1136/bmj.f264 – volume: 34 start-page: 917 issue: 6 year: 2012 ident: 7196_CR75 publication-title: Int J Clin Pharm doi: 10.1007/s11096-012-9694-3 – volume: 12 start-page: 56 issue: 1 year: 2012 ident: 7196_CR41 publication-title: BMC Health Serv Res doi: 10.1186/1472-6963-12-56 – volume: 2 start-page: e000535 issue: 6 year: 2013 ident: 7196_CR78 publication-title: J Am Heart Assoc doi: 10.1161/JAHA.113.000535 – volume: 20 start-page: 86 issue: 1 year: 2020 ident: 7196_CR86 publication-title: BMC Cancer doi: 10.1186/s12885-020-6583-3 – ident: 7196_CR4 – ident: 7196_CR40 doi: 10.1016/j.healthpol.2015.02.016 – volume: 54 start-page: 725 issue: 7 year: 2016 ident: 7196_CR62 publication-title: Med Care doi: 10.1097/MLR.0000000000000549 – volume: 3 start-page: 393 issue: 4 year: 2012 ident: 7196_CR27 publication-title: Eur J Health Econ doi: 10.1007/s10198-011-0311-5 – volume: 55 start-page: 497 issue: 5 year: 2010 ident: 7196_CR82 publication-title: Int J Public Health doi: 10.1007/s00038-010-0132-9 – volume: 93 start-page: 47 year: 2015 ident: 7196_CR54 publication-title: Hungarian Statistical Review – volume: 6 issue: 7 year: 2009 ident: 7196_CR14 publication-title: Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement PLoS Medicine doi: 10.1371/journal.pmed.1000097 – volume: 10 start-page: 53 issue: 1 year: 2015 ident: 7196_CR91 publication-title: Implement Sci doi: 10.1186/s13012-015-0242-0 – volume: 8 start-page: 22 issue: 1 year: 2013 ident: 7196_CR7 publication-title: Implement Sci doi: 10.1186/1748-5908-8-22 – volume: 33 start-page: 339 issue: 4 year: 2008 ident: 7196_CR9 publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2008.00925.x – volume: 25 start-page: 72 issue: 1 year: 2019 ident: 7196_CR44 publication-title: J Manag Care Spec Pharm doi: 10.18553/jmcp.2019.25.1.072 – volume: 304 start-page: 14 year: 2020 ident: 7196_CR74 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2020.01.029 – volume: 6 start-page: 257 issue: 3 year: 2010 ident: 7196_CR42 publication-title: Res Social Adm Pharm doi: 10.1016/j.sapharm.2009.09.003 – volume: 11 start-page: 279 issue: 3 year: 2010 ident: 7196_CR81 publication-title: Eur J Health Econ doi: 10.1007/s10198-009-0174-1 – volume: 6 start-page: 33 issue: 1 year: 2018 ident: 7196_CR24 publication-title: Healthcare. doi: 10.1016/j.hjdsi.2017.09.004 – ident: 7196_CR49 doi: 10.1287/mksc.1100.0566 – ident: 7196_CR3 – volume: 3 start-page: 17 issue: 1 year: 2008 ident: 7196_CR37 publication-title: Subst Abuse Treat Prev Policy doi: 10.1186/1747-597X-3-17 – volume: 64 start-page: 1215 issue: 12 year: 2008 ident: 7196_CR43 publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-008-0549-8 – volume: 111 start-page: 1693 issue: 9 year: 2014 ident: 7196_CR31 publication-title: Br J Cancer doi: 10.1038/bjc.2014.86 – volume: 34 start-page: 2043 issue: 8 year: 2017 ident: 7196_CR73 publication-title: Adv Ther doi: 10.1007/s12325-017-0589-5 – volume: 8 start-page: 179 issue: 3 year: 2012 ident: 7196_CR83 publication-title: J Oncol Pract doi: 10.1200/JOP.2011.000287 – volume: 23 start-page: 327 issue: 3-4 year: 2007 ident: 7196_CR88 publication-title: J Mark Manag doi: 10.1362/026725707X196404 – volume: 72 start-page: 919 issue: 6 year: 2011 ident: 7196_CR60 publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2010.12.027 – volume: 13 start-page: 308 issue: 3 year: 2018 ident: 7196_CR79 publication-title: Int J Stroke doi: 10.1177/1747493017733928 – volume: 27 start-page: 961 issue: 6 year: 2008 ident: 7196_CR66 publication-title: INFORMS doi: 10.1287/mksc.1070.0354 – volume: 14 start-page: 435 issue: 7 year: 2012 ident: 7196_CR33 publication-title: J Clin Hypertens doi: 10.1111/j.1751-7176.2012.00651.x – volume: 18 start-page: 746 issue: 4 year: 2012 ident: 7196_CR18 publication-title: J Eval Clin Pract doi: 10.1111/j.1365-2753.2011.01662.x – volume: 172 start-page: 153 year: 2017 ident: 7196_CR56 publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2016.11.010 – volume: 64 start-page: 324 issue: 4 year: 2013 ident: 7196_CR48 publication-title: Psychiatr Serv doi: 10.1176/appi.ps.201200186 – volume: 14 start-page: 310 issue: 1 year: 2014 ident: 7196_CR22 publication-title: BMC Health Serv Res doi: 10.1186/1472-6963-14-310 – volume: 45 start-page: 657 issue: 4 year: 2015 ident: 7196_CR89 publication-title: Int J Health Serv doi: 10.1177/0020731415585986 – volume: 42 start-page: 185 issue: 2 year: 2017 ident: 7196_CR30 publication-title: J Clin Pharm Ther doi: 10.1111/jcpt.12490 – volume: 37 start-page: 78 year: 2008 ident: 7196_CR80 publication-title: Aust Fam Physician – volume: 17 start-page: 350 issue: 4 year: 2008 ident: 7196_CR26 publication-title: Seizure doi: 10.1016/j.seizure.2007.11.005 – volume: 86 start-page: 392 issue: 2 year: 2020 ident: 7196_CR53 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.14171 – volume: 15 start-page: 35 issue: Suppl 1 year: 2012 ident: 7196_CR46 publication-title: Value Health doi: 10.1016/j.jval.2011.11.025 – volume: 42 start-page: 353 issue: 4 year: 2011 ident: 7196_CR58 publication-title: Int J Psychiatry Med doi: 10.2190/PM.42.4.b – volume: 14 start-page: 469 issue: 1 year: 2014 ident: 7196_CR10 publication-title: BMC Health Serv Res doi: 10.1186/1472-6963-14-469 – volume: 20 start-page: 8 year: 2017 ident: 7196_CR28 publication-title: J Pharm Pharm Sci doi: 10.18433/J30W4F – volume: 10 start-page: 10 issue: 1 year: 2015 ident: 7196_CR77 publication-title: The uptake of medical innovations in the performance of thrombolysis on ischemic stroke patients in Germany: a study based on hospital quality data Implement Sci doi: 10.1186/s13012-014-0196-7 – volume: 9 start-page: 153 issue: 2 year: 2009 ident: 7196_CR45 publication-title: Int J Health Care Finance Econ doi: 10.1007/s10754-009-9062-6 – volume: 6 issue: 7 year: 2009 ident: 7196_CR15 publication-title: PLoS Med doi: 10.1371/journal.pmed.1000100 – volume: 73 start-page: 1208 issue: 8 year: 2011 ident: 7196_CR59 publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2011.06.065 – volume: 56 start-page: 69 issue: 1 year: 2018 ident: 7196_CR51 publication-title: Med Care doi: 10.1097/MLR.0000000000000840 – volume: 37 start-page: 322 issue: 3 year: 2010 ident: 7196_CR39 publication-title: J Behav Health Serv Res doi: 10.1007/s11414-009-9169-z – volume: 29 start-page: 372 issue: 3 year: 2012 ident: 7196_CR61 publication-title: J Prod Innovat Manag doi: 10.1111/j.1540-5885.2012.00912.x – volume: 65 start-page: 141 issue: 2 year: 2009 ident: 7196_CR71 publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-008-0569-4 – volume: 104 start-page: 510 issue: 12 year: 2011 ident: 7196_CR1 publication-title: J Roy Soc Med doi: 10.1258/jrsm.2011.110180 – ident: 7196_CR13 – volume: 26 start-page: 1525 issue: 5 year: 2015 ident: 7196_CR29 publication-title: Osteoporos Int doi: 10.1007/s00198-014-3023-8 – volume: 7 start-page: 399 issue: 4 year: 2009 ident: 7196_CR32 publication-title: Quant Mark Econ doi: 10.1007/s11129-009-9072-1 – volume: 13 issue: 10 year: 2018 ident: 7196_CR36 publication-title: PLoS One doi: 10.1371/journal.pone.0204826 – volume: 8 issue: 3 year: 2019 ident: 7196_CR65 publication-title: J Am Heart Assoc doi: 10.1161/JAHA.118.010484 – volume: 22 start-page: 281 issue: 3 year: 2016 ident: 7196_CR25 publication-title: J Manag Care Spec Pharm. doi: 10.18553/jmcp.2016.22.3.281 – volume: 9 start-page: 166 issue: 2 year: 2020 ident: 7196_CR50 publication-title: Health Policy and Technology doi: 10.1016/j.hlpt.2020.02.007 – volume: 38 start-page: 275 issue: 3 year: 2010 ident: 7196_CR21 publication-title: J Subst Abus Treat doi: 10.1016/j.jsat.2010.01.003 – volume: 42 start-page: 6 issue: 1 year: 2012 ident: 7196_CR76 publication-title: J Subst Abus Treat doi: 10.1016/j.jsat.2011.06.009 |
| SSID | ssj0017827 |
| Score | 2.5345745 |
| SecondaryResourceType | review_article |
| Snippet | Background
Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake... Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake of new... Background Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the uptake... Abstract Background Implementation and uptake of novel and cost-effective medicines can improve patient health outcomes and healthcare efficiency. However, the... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1198 |
| SubjectTerms | Adult Citation management software Clinical medicine Data collection Decision making Drug Prescriptions Drugs Evidence-Based Medicine Expenditures Health Administration Health Informatics Health services Healthcare organizations Humans Implementation Innovation implementation Innovations Medical care Medicine Medicine & Public Health Methods New medicines Nursing Research Organization Patient education Product development Public Health Quality management Research Article structure and delivery of healthcare Systematic review United Kingdom Uptake |
| SummonAdditionalLinks | – databaseName: ABI/INFORM Global dbid: M0C link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9QwDI9gIISE-BhfhYGChMQDVGubNE15QdvExAObeAC0t8hNmnECtce1x9-PnbZ3dIi98HRS4_TqxrFdO_6ZsZcuLbyQso6rTLuYSjtjrcDFOrPO17krXAjof_1YnJ7qs7Py0xhw68ZjlZNODIratZZi5PvoppcJqlKh3y1_xtQ1irKrYwuNq-waeTZ0pO8kOdpkEdD6FVOhjFb7Hdo26mWQpVS2U6pYzoxRwOz_WzP_YZouHpu8kDsNJun4zv8yc5fdHp1RfjBIzz12pW522Y2TMd2-y24NQT0-1CrdZ-4QVtThruPQOO7BDhDfLV7oW46uJF8ve_he89ZzdNf5lLjv-KJBgqkKk0-lWW858C2UNB_KaB6wL8fvPx99iMc2DbFVSdHHdZ67qnQigRxAVaBc5TP8LVWe6QRk6Vzp8asJXRXKGQKgevUA3oEqMnwL4iHbadqmfsy4FqmzaQoVulEyxbuqOg-ghCB9AoWLWDqtl7Ejhjm10vhhwreMVmZYY4NrbMIaGxmx15s5ywHB41LqQxKDDSWhb4cL7ercjJvZ6Ep4nYH3aWmlTQRkTih0bGtlna2UiNgrEiJDOgIfz8JY6oBMEtqWOVA6VdRKEf9ub0aJe9vOhyf5MaNu6cxWeCL2YjNMM-m8XFO360CDjoZIZRqxR4PUblgSspCJoNnFTJ5nPM9HmsW3gDweuiEkRcTeTJK_fax_v9Mnl3PxlN3MaE9SrD7fYzv9al0_Y9ftr37RrZ6HHf0b_uxSEw priority: 102 providerName: ProQuest – databaseName: Springer LINK dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Zi9YwMOgqIojH6mp1lQiCD1psmjRJfdsVFx90EY9l38I0afRjpV2-9vP3O0mPtesB-lRoJm0ymSuZzAwhTxxTngtRp1WuXRpCO1MtwaU6t87XhVMuHugfvVWHh_r4uHw_BoV10233ySUZJXVkay1fdKiZQiWCnIWgm1Km4iK5hOpOh4INHz4ezb4D1HlqCo_5bb-FCoqZ-n-Vxz8ppPOXJc95TKMiOrjxf1O4Sa6PhifdGyjlFrlQN9vkyrvRtb5Nrg0HeHSIS7pN3D6sQzW7jkLjqAc7pPNu8UXfUjQb6ea0h5Oatp6iaU4nJ31HVw0CTBGXdArDekmBnqWNpkPIzB3y-eD1p1dv0rEkQ2plpvq0LgpXlY5nUADICqSrfI7PUha5zkCUzpUed0holgT_IACKUg_gHUiVZ1rwHbLVtE19j1DNmbOMQYUmk2D4VVkXMQEhCJ-Bcglh0yoZO-YrD2Uzvpm4b9HSDOg0iE4T0WlEQp7NfU6HbB1_hd4Piz9Dhkzb8UW7_mJGxjW64l7n4D0rrbAZh9xxiUZsLa2zleQJeRpIxwR5gMOzMIY14CRDZi2zJzWToWwi_m53AYl8bJfNE_GZUY50BjenJaJNcZ2Qx3Nz6BnuxjV1u4kwaFRwJlhC7g60Ok-JCyUyHnqrBRUv5rxsaVZfY5bxWPkgUwl5PtHy2bD-jNP7_wb-gFzNAzuEc_pil2z16039kFy23_tVt34U-foH_b5ILA priority: 102 providerName: Springer Nature |
| Title | Barriers and facilitators to the uptake of new medicines into clinical practice: a systematic review |
| URI | https://link.springer.com/article/10.1186/s12913-021-07196-4 https://www.ncbi.nlm.nih.gov/pubmed/34740338 https://www.proquest.com/docview/2599084738 https://www.proquest.com/docview/2594293141 https://pubmed.ncbi.nlm.nih.gov/PMC8570007 https://doaj.org/article/8b3f82aff19c4c03a2d36163e6cdcb63 |
| Volume | 21 |
| WOSCitedRecordID | wos000714917700005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: ABI/INFORM Collection customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: 7WY dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/abicomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ABI/INFORM Global customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: M0C dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/abiglobal providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: M0T dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: 7RV dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagcEBCiGcJlJWRkDhA1DhxbIdbt2oFEl2tlrIsJ2tix2IFSqp98PsZO8m2KQIuXCZSPE5sz9geP-YbQl5ZJl3GeRWXqbKxd-2MlQAbq9RYV-VW2rChP_8oJxO1WBTTK6G-_J2wFh64bbhDVWZOpeAcKww3SQapzQQaEZUw1pQi4HwmsugXU935Ac57sneRUeJwjbOaj2KQMu-wU4iYD6ahgNb_-5h8ZVK6fmHy2qlpmIxO75N7nRVJj9rSPyA3qvohudtuwdHWs-gRsWNY-Xh0awq1pQ5MC8jd4ItNQ9Hwo9uLDXyvaOMoGte0P2Zf02WNDL3PJO0dqd5RoJfAz7R1enlMPp-enB-_j7ugCrERidzEVZ7bsrBZAjmAKEHY0qX4LESeqgR4YW3hcI2DhoU_4QPAwdABOAtCponi2ROyVzd19ZRQlTFrGIMSjR7O8KuiygOEIHCXgLQRYX0ba9MhjvvAFz90WHkooVu5aJSLDnLRPCJvdnkuWryNv3KPveh2nB4rO7xADdKdBul_aVBEXnvBa9-jsXgGOscErKTHxtJHQjHhAx_i7w4GnNgTzTC5Vx3djQRrjcvLAptNZioiL3fJPqe_3VZXzTbwoFmQMc4ist9q2q5KGZc8yXxuOdDBQZ2HKfXyW8AJD7ELEhmRt722Xhbrz2367H-06XNyJ_W9ze-_5wdkb7PaVi_IbfNzs1yvRuSmnM09_fLV04UMVI3IrfHJZDobhb6M9Cw5DvQcU6Yfzqaee_Zp_gudPEum |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3JbtQw9KkUBEiIpWyBAkYCcYCoWRzHQUKoLVStOq04FNSbcbzACJQMkxkQP8U38uwkM6SI3nrgFCl-TvySt9lvA3ii49ymlJqwTLgOXWpnyJnUIU-UtibTufYH-h9G-eEhPz4u3q3Arz4XxoVV9jLRC2pdK3dGvoFmehGhKE3568m30HWNct7VvoVGSxb75ucP3LI1r_be4P99miQ7b4-2d8Ouq0CoWJTPQpNluix0GslMSlZKpkub4LVgWcIjSQutC4tGPmpW5-KSEqWBldJqyfIEV5Dic8_BeUqRPVyoYLS98Fqgts37xBzONhrUpa53QhK7NKGChXSg_HyPgL81wR-q8GSY5glfrVeBO9f-t493Ha52xjbZbLnjBqyYag0uHnThBGtwpT20JG0u1k3QW3LqOvg1RFaaWKnaEuY13pjVBE1lMp_M5BdDaktwO0L6wISGjCsE6LNMSZ969pJIsiyVTdo0oVvw_kxwvg2rVV2Zu0B4GmsVx7JEM5HG-FRmMl90UVIbyVwHEPf0IVRXo921Cvkq_F6NM9HSlECaEp6mBA3g-WLOpK1Qcir0liO7BaSrLu5v1NNPohNWgpep5Ym0Ni4UVVEqE50yNNwNU1qVLA3gmSNa4WQgLk_JLpUDkXTVxMQm4zFzrSLxdesDSJRdajjc06voZGcjlsQawOPFsJvp4gErU889DBpSaUzjAO60XLJAKaU58qabnQ_4Z4DzcKQaf_aV1X23hygP4EXPactl_fub3jsdi0dwaffoYCRGe4f79-Fy4uSB80tk67A6m87NA7igvs_GzfShlyYEPp41B_4Ga-aviQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ri9QwEA96yiGIj_NVPTWC4Act1zRpkvrtTl0Uz-VAPe5bmOahi9Iu265_v0na7l3PB4ifFprJbjM7k0wy-f0GoaeGCEcZs2mVS5MGaGcqOZhU5to4Wxhh4oH-8aGYz-XJSXl0BsUfb7uPKcke0xBYmupub2lc7-KS77V-lQpVCXISADglT9lFdImFi_Rhv_7xeJNH8OufGKEyv-03WY4ia_-vc_OZxen8xclz2dO4KM2u__9wbqBrQ0CK93sLuoku2HoHbX8YUu476Gp_sId7vNItZA5gFarctRhqgx3onua78Q-6BvtwEq-XHXyzuHHYh-x4TN63eFF7gRGJiUd41ksM-JROGvdQmtvo8-zNp1dv06FUQ6p5JrrUFoWpSkMzKAB4BdxULvefJS9ymQErjSmd3zn5cCXkDQH8FOsAnAEu8kwyegdt1U1t7yEsKTGaEKh8KMWI_1Zui0hMCMxlIEyCyPiPKT3wmIdyGt9V3M9Irnp1Kq9OFdWpWIKeb_osexaPv0ofBEPYSAYG7vigWX1Rg0MrWVEnc3COlJrpjEJuKPfBreXa6IrTBD0LZqTCPOFfT8MAd_CDDIxbap9LwkM5Rf9zuxNJ79962jwaohrml1b5TWvp1SaoTNCTTXPoGe7M1bZZRxkfbFDCSILu9na7GRJlgmU09BYTi56MedpSL75G9vFYESETCXox2vXpa_1Zp_f_Tfwx2j56PVOH7-bvH6ArefCMcJRf7KKtbrW2D9Fl_aNbtKtH0d1_AtDFU_Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Barriers+and+facilitators+to+the+uptake+of+new+medicines+into+clinical+practice%3A+a+systematic+review&rft.jtitle=BMC+health+services+research&rft.au=Kristina+Medlinskiene&rft.au=Justine+Tomlinson&rft.au=Iuri+Marques&rft.au=Sue+Richardson&rft.date=2021-11-05&rft.pub=BMC&rft.eissn=1472-6963&rft.volume=21&rft.issue=1&rft.spage=1&rft.epage=28&rft_id=info:doi/10.1186%2Fs12913-021-07196-4&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_8b3f82aff19c4c03a2d36163e6cdcb63 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6963&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6963&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6963&client=summon |